A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare any good and bad effects of using radium-223 along
with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped
show that the combination is safe, but the combination has not been proven to work better
than either drug alone. The goal of this study is to find out if combining docetaxel and
radium-223 is better than giving either drug by itself.